GLP-1 agonists (Byetta, etc) are a good choice for weight loss in patients WITHOUT diabetes.

January 1

This isn’t completely true. GLP-1 agonists do result in short-term weight loss, but safety is a concern.

Alternative weight loss meds are tempting in light of all the cardiovascular and other concerns with antiobesity drugs.

GLP-1 agonists seem to cause weight loss by slowing gastric motility, increasing satiety, and suppressing appetite.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote